APA (7th ed.) Citation

D, D., T, D., A, C., AI, B., TK, D., TT, T., & SK, P. (2022). Nek2 Kinase Signaling in Malaria, Bone, Immune and Kidney Disorders to Metastatic Cancers and Drug Resistance: Progress on Nek2 Inhibitor Development. Molecules (Basel, Switzerland), 27(2), . https://doi.org/10.3390/molecules27020347

Chicago Style (17th ed.) Citation

D, Dana, Das T, Choi A, Bhuiyan AI, Das TK, Talele TT, and Pathak SK. "Nek2 Kinase Signaling in Malaria, Bone, Immune and Kidney Disorders to Metastatic Cancers and Drug Resistance: Progress on Nek2 Inhibitor Development." Molecules (Basel, Switzerland) 27, no. 2 (2022). https://doi.org/10.3390/molecules27020347.

MLA (9th ed.) Citation

D, Dana, et al. "Nek2 Kinase Signaling in Malaria, Bone, Immune and Kidney Disorders to Metastatic Cancers and Drug Resistance: Progress on Nek2 Inhibitor Development." Molecules (Basel, Switzerland), vol. 27, no. 2, 2022, https://doi.org/10.3390/molecules27020347.